Exelixis Other Stockholder Equity vs Common Stock Analysis

EXEL Stock

USD 20.89 0.34 1.60%

Exelixis financial indicator trend analysis is much more than just examining Exelixis latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Exelixis is a good investment. Please check the relationship between Exelixis Other Stockholder Equity and its Common Stock accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.

Other Stockholder Equity vs Common Stock

Other Stockholder Equity vs Common Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Exelixis Other Stockholder Equity account and Common Stock. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Exelixis' Other Stockholder Equity and Common Stock is -0.59. Overlapping area represents the amount of variation of Other Stockholder Equity that can explain the historical movement of Common Stock in the same time period over historical financial statements of Exelixis, assuming nothing else is changed. The correlation between historical values of Exelixis' Other Stockholder Equity and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Stockholder Equity of Exelixis are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Other Stockholder Equity i.e., Exelixis' Other Stockholder Equity and Common Stock go up and down completely randomly.

Correlation Coefficient

-0.59

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Other Stockholder Equity

Common Stock

Most indicators from Exelixis' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Exelixis current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.At this time, Exelixis' Selling General Administrative is quite stable compared to the past year. Tax Provision is expected to rise to about 32.5 M this year, although the value of Sales General And Administrative To Revenue will most likely fall to 0.24.

	2021	2022	2023	2024 (projected)
Gross Profit	1.4B	1.6B	1.8B	1.8B
Total Revenue	1.4B	1.6B	1.8B	1.9B

Gross Profit Total Revenue

Exelixis fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Common Stock Shares Outstanding	Other Stockholder Equity	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Other Liab	Other Assets	Long Term Debt
Total Assets		0.99	0.72	0.61	0.61	-0.3	0.88	0.85	0.85	-0.68	0.95	0.75	0.95	0.86	0.94	0.94	0.96	-0.21	0.89	0.34	0.96	-0.34	-0.33	-0.03	0.95	-0.55
Total Stockholder Equity	0.99		0.78	0.61	0.62	-0.41	0.83	0.78	0.8	-0.76	0.92	0.77	0.92	0.79	0.95	0.95	0.97	-0.34	0.84	0.2	0.97	-0.39	-0.26	-0.09	0.95	-0.61
Retained Earnings	0.72	0.78		0.08	0.25	-0.51	0.63	0.46	0.64	-0.61	0.67	0.49	0.7	0.63	0.66	0.69	0.69	-0.56	0.55	-0.18	0.68	-0.6	0.34	-0.35	0.74	-0.58
Common Stock Shares Outstanding	0.61	0.61	0.08		0.78	-0.27	0.37	0.5	0.3	-0.63	0.51	0.73	0.46	0.28	0.71	0.64	0.66	-0.09	0.52	0.38	0.69	-0.03	-0.67	0.24	0.54	-0.4
Other Stockholder Equity	0.61	0.62	0.25	0.78		-0.09	0.42	0.32	0.36	-0.5	0.53	0.68	0.51	0.36	0.64	0.59	0.59	0.01	0.34	0.29	0.64	-0.15	-0.59	-0.23	0.57	-0.07
Short Long Term Debt Total	-0.3	-0.41	-0.51	-0.27	-0.09		-0.06	-0.1	-0.09	0.78	-0.2	-0.35	-0.16	-0.02	-0.4	-0.48	-0.4	0.86	-0.15	0.57	-0.41	0.46	-0.32	-0.19	-0.34	0.87
Other Current Liab	0.88	0.83	0.63	0.37	0.42	-0.06		0.91	0.85	-0.46	0.94	0.62	0.86	0.92	0.8	0.84	0.81	0.01	0.9	0.52	0.82	-0.22	-0.25	-0.01	0.79	-0.36
Total Current Liabilities	0.85	0.78	0.46	0.5	0.32	-0.1	0.91		0.82	-0.46	0.88	0.57	0.83	0.86	0.77	0.81	0.79	0.01	0.95	0.59	0.79	-0.17	-0.37	0.27	0.76	-0.5
Property Plant And Equipment Net	0.85	0.8	0.64	0.3	0.36	-0.09	0.85	0.82		-0.32	0.91	0.38	0.96	0.98	0.64	0.75	0.7	0.07	0.78	0.45	0.68	-0.22	-0.16	0.09	0.86	-0.42
Net Debt	-0.68	-0.76	-0.61	-0.63	-0.5	0.78	-0.46	-0.46	-0.32		-0.55	-0.86	-0.47	-0.32	-0.82	-0.82	-0.76	0.66	-0.52	0.15	-0.82	0.4	0.07	-0.06	-0.62	0.77
Accounts Payable	0.95	0.92	0.67	0.51	0.53	-0.2	0.94	0.88	0.91	-0.55		0.63	0.94	0.93	0.86	0.89	0.89	-0.08	0.91	0.43	0.88	-0.26	-0.25	0.04	0.9	-0.49
Cash	0.75	0.77	0.49	0.73	0.68	-0.35	0.62	0.57	0.38	-0.86	0.63		0.54	0.43	0.89	0.8	0.79	-0.3	0.62	0.24	0.88	-0.22	-0.36	-0.07	0.63	-0.43
Non Current Assets Total	0.95	0.92	0.7	0.46	0.51	-0.16	0.86	0.83	0.96	-0.47	0.94	0.54		0.93	0.79	0.85	0.84	-0.06	0.84	0.39	0.82	-0.29	-0.27	-0.02	0.95	-0.46
Non Currrent Assets Other	0.86	0.79	0.63	0.28	0.36	-0.02	0.92	0.86	0.98	-0.32	0.93	0.43	0.93		0.67	0.76	0.72	0.13	0.83	0.53	0.71	-0.22	-0.18	0.08	0.82	-0.36
Cash And Short Term Investments	0.94	0.95	0.66	0.71	0.64	-0.4	0.8	0.77	0.64	-0.82	0.86	0.89	0.79	0.67		0.93	0.98	-0.33	0.85	0.25	1.0	-0.35	-0.36	-0.04	0.84	-0.57
Net Receivables	0.94	0.95	0.69	0.64	0.59	-0.48	0.84	0.81	0.75	-0.82	0.89	0.8	0.85	0.76	0.93		0.91	-0.36	0.81	0.21	0.95	-0.32	-0.28	0.03	0.92	-0.66
Short Term Investments	0.96	0.97	0.69	0.66	0.59	-0.4	0.81	0.79	0.7	-0.76	0.89	0.79	0.84	0.72	0.98	0.91		-0.33	0.89	0.24	0.98	-0.39	-0.33	-0.03	0.87	-0.6
Non Current Liabilities Total	-0.21	-0.34	-0.56	-0.09	0.01	0.86	0.01	0.01	0.07	0.66	-0.08	-0.3	-0.06	0.13	-0.33	-0.36	-0.33		-0.08	0.74	-0.33	0.46	-0.42	0.22	-0.28	0.69
Other Current Assets	0.89	0.84	0.55	0.52	0.34	-0.15	0.9	0.95	0.78	-0.52	0.91	0.62	0.84	0.83	0.85	0.81	0.89	-0.08		0.5	0.86	-0.23	-0.32	0.17	0.79	-0.52
Total Liab	0.34	0.2	-0.18	0.38	0.29	0.57	0.52	0.59	0.45	0.15	0.43	0.24	0.39	0.53	0.25	0.21	0.24	0.74	0.5		0.25	0.22	-0.57	0.33	0.19	0.2
Total Current Assets	0.96	0.97	0.68	0.69	0.64	-0.41	0.82	0.79	0.68	-0.82	0.88	0.88	0.82	0.71	1.0	0.95	0.98	-0.33	0.86	0.25		-0.35	-0.34	-0.03	0.87	-0.59
Short Term Debt	-0.34	-0.39	-0.6	-0.03	-0.15	0.46	-0.22	-0.17	-0.22	0.4	-0.26	-0.22	-0.29	-0.22	-0.35	-0.32	-0.39	0.46	-0.23	0.22	-0.35		-0.16	0.13	-0.33	0.43
Common Stock	-0.33	-0.26	0.34	-0.67	-0.59	-0.32	-0.25	-0.37	-0.16	0.07	-0.25	-0.36	-0.27	-0.18	-0.36	-0.28	-0.33	-0.42	-0.32	-0.57	-0.34	-0.16		-0.16	-0.25	-0.19
Other Liab	-0.03	-0.09	-0.35	0.24	-0.23	-0.19	-0.01	0.27	0.09	-0.06	0.04	-0.07	-0.02	0.08	-0.04	0.03	-0.03	0.22	0.17	0.33	-0.03	0.13	-0.16		-0.1	-0.4
Other Assets	0.95	0.95	0.74	0.54	0.57	-0.34	0.79	0.76	0.86	-0.62	0.9	0.63	0.95	0.82	0.84	0.92	0.87	-0.28	0.79	0.19	0.87	-0.33	-0.25	-0.1		-0.55
Long Term Debt	-0.55	-0.61	-0.58	-0.4	-0.07	0.87	-0.36	-0.5	-0.42	0.77	-0.49	-0.43	-0.46	-0.36	-0.57	-0.66	-0.6	0.69	-0.52	0.2	-0.59	0.43	-0.19	-0.4	-0.55

Click cells to compare fundamentals

Exelixis Account Relationship Matchups

Exelixis fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.9B	2.1B	2.6B	3.1B	2.9B	3.1B
Total Stockholder Equity	1.7B	1.9B	2.2B	2.5B	2.3B	2.4B
Retained Earnings	(559.4M)	(447.6M)	(216.5M)	(34.2M)	(173.4M)	(182.0M)
Common Stock Shares Outstanding	315.0M	318.0M	322.4M	324.6M	321.5M	178.5M
Liabilities And Stockholders Equity	1.9B	2.1B	2.6B	3.1B	2.9B	3.1B
Other Stockholder Equity	2.2B	2.3B	2.4B	2.5B	2.4B	1.4B
Short Long Term Debt Total	50.7M	49.1M	51.3M	190.2M	189.9M	156.7M
Other Current Liab	21.7M	176.2M	313.3M	267.5M	329.4M	345.9M
Total Current Liabilities	142.7M	204.7M	337.6M	324.4M	394.3M	414.0M
Property Plant And Equipment Net	90.7M	67.4M	104.0M	401.2M	470.9M	494.4M
Net Debt	(215.8M)	(270.1M)	(595.9M)	(311.0M)	(73.1M)	(69.4M)
Accounts Payable	11.6M	23.6M	24.3M	32.7M	33.8M	35.5M
Cash	266.5M	319.2M	647.2M	501.2M	263.0M	190.9M
Non Current Assets Total	874.5M	691.9M	781.5M	1.5B	1.6B	1.7B
Non Currrent Assets Other	11.3M	71.9M	131.0M	290.6M	334.2M	350.9M
Cash And Short Term Investments	852.2M	1.2B	1.5B	1.3B	995.3M	1.0B
Net Receivables	119.1M	160.9M	282.7M	214.8M	237.4M	249.3M
Short Term Investments	585.7M	887.3M	819.9M	807.3M	732.3M	768.9M
Non Current Liabilities Total	57.0M	53.6M	68.0M	258.7M	284.2M	213.1M
Other Current Assets	27.0M	57.0M	57.5M	62.2M	67.9M	71.3M
Total Liab	199.7M	258.2M	405.6M	583.1M	678.4M	370.3M
Total Current Assets	1.0B	1.4B	1.8B	1.6B	1.3B	1.4B
Accumulated Other Comprehensive Income	3.1M	4.5M	(758K)	(14.5M)	(3.8M)	(3.9M)
Short Term Debt	2.7M	3.0M	8.7M	17.7M	25.7M	50.4M
Common Stock	305K	312K	319K	324K	303K	287.9K
Other Liab	8.9M	4.5M	16.8M	68.5M	78.8M	83.4M
Other Assets	185.3M	187.1M	197.5M	286.9M	329.9M	346.4M
Common Stock Total Equity	300K	305K	312K	324K	372.6K	391.2K
Inventory	12.9M	21.0M	27.5M	33.3M	17.3M	9.5M
Property Plant And Equipment Gross	90.7M	67.4M	144.9M	462.1M	551.2M	578.8M
Property Plant Equipment	48.9M	67.4M	149.2M	110.6M	127.2M	133.6M
Current Deferred Revenue	106.7M	1.8M	8.7M	6.6M	5.4M	5.1M
Net Tangible Assets	1.6B	1.8B	2.0B	2.4B	2.8B	2.9B
Retained Earnings Total Equity	(880.4M)	(559.4M)	(447.6M)	(34.2M)	(39.4M)	(41.3M)
Capital Surpluse	2.2B	2.2B	2.3B	2.5B	2.9B	2.1B

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Exelixis using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

When determining whether Exelixis is a strong investment it is important to analyze Exelixis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Exelixis' future performance. For an informed investment choice regarding Exelixis Stock, refer to the following important reports:

How To Invest In Exelixis

Details

Is Exelixis Stock a good investment?

Details

What is Exelixis' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.

Note that the Exelixis information on this page should be used as a complementary analysis to other Exelixis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Exelixis Stock analysis

When running Exelixis' price analysis, check to measure Exelixis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Exelixis is operating at the current time. Most of Exelixis' value examination focuses on studying past and present price action to predict the probability of Exelixis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Exelixis' price. Additionally, you may evaluate how the addition of Exelixis to your portfolios can decrease your overall portfolio volatility.

	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like

Is Exelixis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

0.65

Revenue Per Share

5.914

Quarterly Revenue Growth

0.04

Return On Assets

0.043

Return On Equity

0.0876

The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Exelixis Other Stockholder Equity vs Common Stock Analysis

Other Stockholder Equity vs Common Stock

Other Stockholder Equity vs Common Stock Correlation Analysis

Correlation Coefficient

Other Stockholder Equity

Common Stock

Exelixis fundamental ratios Correlations

Exelixis Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Exelixis fundamental ratios Accounts

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Exelixis Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Stockholder Equity	+ 0.99	Total Assets
Non Currrent Assets Other	+ 0.98	Property Plant And Equipment Net
Short Term Investments	+ 0.98	Cash And Short Term Investments
Total Current Assets	+ 0.98	Short Term Investments
Short Term Investments	+ 0.97	Total Stockholder Equity

Cash	- 0.86	Net Debt
Total Current Assets	- 0.82	Net Debt
Net Receivables	- 0.82	Net Debt
Cash And Short Term Investments	- 0.82	Net Debt
Short Term Investments	- 0.76	Net Debt
Net Debt	- 0.76	Total Stockholder Equity